DE60211651D1 - Proteom-analyseverfahren - Google Patents

Proteom-analyseverfahren

Info

Publication number
DE60211651D1
DE60211651D1 DE60211651T DE60211651T DE60211651D1 DE 60211651 D1 DE60211651 D1 DE 60211651D1 DE 60211651 T DE60211651 T DE 60211651T DE 60211651 T DE60211651 T DE 60211651T DE 60211651 D1 DE60211651 D1 DE 60211651D1
Authority
DE
Germany
Prior art keywords
proteome analysis
analysis procedure
membrane proteins
proteome
interacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60211651T
Other languages
English (en)
Other versions
DE60211651T2 (de
Inventor
Kenji Tanaka
Lyang-Ja Lee
Hiromichi Mukai
Koji Munechika
Hisashi Arikuni
Mieko Shiwa
Bungo Ochiai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Protosera Inc
Original Assignee
Protosera Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protosera Inc filed Critical Protosera Inc
Publication of DE60211651D1 publication Critical patent/DE60211651D1/de
Application granted granted Critical
Publication of DE60211651T2 publication Critical patent/DE60211651T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G01N27/447—Systems using electrophoresis
DE60211651T 2001-01-09 2002-01-09 Proteom-analyseverfahren Expired - Lifetime DE60211651T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US26043301P 2001-01-09 2001-01-09
US260433P 2001-01-09
US27298101P 2001-03-02 2001-03-02
US272981P 2001-03-02
US10/038,918 US20030044843A1 (en) 2001-01-09 2002-01-03 Novel proteome analysis method and devices therefor
US38918 2002-01-03
PCT/JP2002/000029 WO2002056026A1 (en) 2001-01-09 2002-01-09 Novel proteome analysis method and devices therefor

Publications (2)

Publication Number Publication Date
DE60211651D1 true DE60211651D1 (de) 2006-06-29
DE60211651T2 DE60211651T2 (de) 2007-05-10

Family

ID=27365472

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60211651T Expired - Lifetime DE60211651T2 (de) 2001-01-09 2002-01-09 Proteom-analyseverfahren

Country Status (10)

Country Link
US (1) US20030044843A1 (de)
EP (1) EP1352249B1 (de)
JP (1) JP4166572B2 (de)
KR (1) KR100853129B1 (de)
CN (1) CN1297820C (de)
AT (1) ATE327511T1 (de)
AU (1) AU2002219562B2 (de)
CA (1) CA2434243C (de)
DE (1) DE60211651T2 (de)
WO (1) WO2002056026A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8147824B2 (en) 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US20030129666A1 (en) * 2001-01-09 2003-07-10 Mitsubishi Pharma Corporation Novel proteome analysis method and devices therefor
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
EP1550862B1 (de) * 2002-10-04 2012-01-25 Protosera Inc. Verfahren zur identifizierung eines analyts durch gelelektrophorese - massenspektrometrie
CN1304843C (zh) * 2003-07-02 2007-03-14 许洋 用于生物样品分析的蛋白指纹法
US20050032113A1 (en) * 2003-07-17 2005-02-10 Mitsubishi Pharma Corporation Membrane protein library for proteome analysis and method for preparing same
EP1591783B1 (de) * 2004-04-28 2008-02-20 Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. Verfahren zum Nachweis und zur Analyse von makromolekularen Komplexen
JP4549803B2 (ja) * 2004-10-08 2010-09-22 富士フイルム株式会社 スクリーニングシステム
SE0403139D0 (sv) * 2004-12-23 2004-12-23 Nanoxis Ab Device and use thereof
US20060266941A1 (en) * 2005-05-26 2006-11-30 Vestal Marvin L Method and apparatus for interfacing separations techniques to MALDI-TOF mass spectrometry
KR100691528B1 (ko) * 2005-06-09 2007-03-09 강원대학교산학협력단 단백질 칩 분석용 표면 플라즈몬 주사 현미경 장치
JP5142458B2 (ja) * 2005-06-30 2013-02-13 キヤノン株式会社 標的物質捕捉分子、標的物質捕捉用の素子、これらを用いた標的物質検出用の装置及びキット、並びに、標的物質の検出方法
US10117900B2 (en) 2005-11-09 2018-11-06 Athersys, Inc. MAPC treatment of brain injuries and diseases
US11000546B2 (en) 2005-11-09 2021-05-11 Athersys, Inc. Immunomodulatory properties of MAPCs and uses thereof
CA3124132A1 (en) 2006-01-23 2007-08-02 Abt Holding Company Mapc therapeutics without adjunctive immunosuppressive treatment
US7879799B2 (en) * 2006-08-10 2011-02-01 Institute For Systems Biology Methods for characterizing glycoproteins and generating antibodies for same
US8959448B2 (en) * 2007-04-17 2015-02-17 Emd Millipore Corporation Graphical user interface for analysis and comparison of location-specific multiparameter data sets
US10627412B2 (en) 2010-03-17 2020-04-21 Kagoshima University Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same
EP2587245A4 (de) * 2010-06-22 2017-08-30 Universal Bio Research Co., Ltd. Vorrichtung zum aufspüren biologisch relevanter substanzen und system zum sammeln biologisch relevanter substanzen
DE102011109063B3 (de) 2011-07-28 2012-12-20 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Verfahren zum Nachweis von Biomolekülen
CN103135309B (zh) * 2011-11-22 2017-11-17 索尼公司 电泳装置、电泳装置的制造方法、以及显示器
CN103163009A (zh) * 2011-12-14 2013-06-19 天津市国际生物医药联合研究院 鉴定蛋白质的糖基化修饰位点的方法
CN104655737B (zh) * 2013-11-18 2017-02-01 维亚生物科技(上海)有限公司 基于液质联用检测膜蛋白与配体亲和力的混合物筛选方法
EP4086618A1 (de) * 2014-01-15 2022-11-09 Caliper Life Sciences, Inc. System für ein mikrofluidisches immunoassay unter verwendung magnetischer kügelchen
WO2019246632A1 (en) * 2018-06-22 2019-12-26 The Regents Of The University Of Colorado A Body Corporate Use of cannabinoids to increase the lipid order of cell membranes
GB201814454D0 (en) 2018-09-05 2018-10-17 Univ Oxford Innovation Ltd Detection of membrane proteins
CN114112980B (zh) * 2022-01-24 2022-05-10 武汉宏韧生物医药股份有限公司 一种基于数据分析的药物组分检测方法与系统

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789734A (en) * 1985-08-06 1988-12-06 La Jolla Cancer Research Foundation Vitronectin specific cell receptor derived from mammalian mesenchymal tissue
US5118937A (en) * 1989-08-22 1992-06-02 Finnigan Mat Gmbh Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
DE4017805C2 (de) * 1989-08-22 1998-03-26 Finnigan Mat Gmbh Verfahren, Präparat und Vorrichtung zur Bereitstellung eines Analytes für eine Untersuchung
US5585275A (en) * 1992-09-02 1996-12-17 Arris Pharmaceutical Corporation Pilot apparatus for peptide synthesis and screening
DE19618032C2 (de) * 1996-05-04 2000-04-13 Bruker Daltonik Gmbh Lagerfähig vorpräparierte Maldi-Probenträger
CN1101440C (zh) * 1998-07-27 2003-02-12 中国科学院长春应用化学研究所 含稀土有机/无机纳米杂化发光材料的合成方法
CA2361013A1 (en) * 1999-01-25 2000-07-27 Minerva Biotechnologies Corporation Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases

Also Published As

Publication number Publication date
WO2002056026B1 (en) 2002-09-19
ATE327511T1 (de) 2006-06-15
AU2002219562B2 (en) 2006-07-06
CA2434243C (en) 2010-12-07
JP4166572B2 (ja) 2008-10-15
US20030044843A1 (en) 2003-03-06
EP1352249A1 (de) 2003-10-15
KR20030069205A (ko) 2003-08-25
WO2002056026A1 (en) 2002-07-18
KR100853129B1 (ko) 2008-08-20
DE60211651T2 (de) 2007-05-10
EP1352249B1 (de) 2006-05-24
JP2004518118A (ja) 2004-06-17
CN1297820C (zh) 2007-01-31
CN1496481A (zh) 2004-05-12
CA2434243A1 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
DE60211651D1 (de) Proteom-analyseverfahren
AU2001259785A1 (en) Microfluidics devices and methods for performing cell based assays
HUP0200400A2 (hu) Fehérjék izolálása és elemzése
DK1502102T3 (da) Forbindelser og fremgangsmåder til analysering af proteomet
AU2002367206A1 (en) Analysis system for determining an analyte concentration, taking into consideration sample- and analyte-independent light-intensity changes
PL1699822T3 (pl) Białka fuzyjne IL-7 z częściami przeciwciała, ich otrzymywanie oraz ich zastosowanie
ES2316597T8 (es) Instrumentos analíticos, biosensores y métodos
DK1293574T3 (da) Reagenser, fremgangsmåder og indretninger til bestemmelse af analytter
TW200512457A (en) Method of diagnosing SARS corona virus infection
IL196902A (en) Collections of captive compounds, and methods for proteome analysis
PT1370571E (pt) Processos e aparelhos para analises qualitativas e quantitativas, isentas de gel, do proteoma e as suas utilizacoes
EP1623227A4 (de) Proteine, sensoren und verfahren zur charakterisierung von analyten damit
DK1309692T3 (da) Anti-IL12-antistoffer, præparater, fremgangsmåder og anvendelser
ATE466659T1 (de) Probenahmesystem mit phosphataseinhibitor
ATE410436T1 (de) Bibliothek aus membranproteinen zur analyse des proteoms und verfahren zu deren herstellung
WO2003062402A3 (en) Use of collections of binding sites for sample profiling and other applications
ATE288589T1 (de) Verfahren zur analyse von proteinen
AU2001263943A1 (en) Method for detecting alpha-oxoaldehydes in the whole blood, blood plasma and/or serum of a patient
DK1185873T3 (da) Reportermolekyler og fremgangsmåde til analyse af höjspecifitetsproteaseraktivitet
BR0300368B1 (pt) máscara, dispositivo e método para depositar reagentes sobre um suporte analítico para amostras biológicas, método para detectar os constituintes de uma ou mais amostras biológicas por imunofixação, e, kit.
MXPA02005109A (es) Metodo para calibrar un analizador de muestras.
WO2003049602A3 (en) Diagnostic methods for protein profiling
WO2004045364A3 (en) Methods of detecting ovarian neoplasia
SE0102896D0 (sv) System and method for blood analysis
DE60226244D1 (de) Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind

Legal Events

Date Code Title Description
8364 No opposition during term of opposition